Steven Cohen Exact Sciences Corp Call Options Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $7.32 Million - $9.59 Million	130,000 Added 325.0%	170,000 $11.7 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $2.36 Million - $3.03 Million	40,000 New	40,000 $2.96 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $799,250 - $1.23 Million	25,000 New	25,000 $812,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.